Varian receives China NMPA approval for cancer treatment system

[Image from Varian Medical Systems]

Varian has received approval from China’s National Medical Product Administration for its Halcyon system to treat cancer.

The Halcyon system is designed to treat cancer patients with radiotherapy to treat lung, prostate, breast, head & neck and other forms of cancer. The system has a human-centered and user-friendly design to improve clinical workflow, accelerate installation timeframes, expedite commissioning, simplify training and automate treatment.

Get the full story on our sister site Medical Design & Outsourcing.

The post Varian receives China NMPA approval for cancer treatment system appeared first on MassDevice.

from MassDevice https://ift.tt/2FOQYEl